Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
Completed
Conditions studied: Thromboembolism, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: A test that detects abnormal blood clotting in patients with cancer may help doctors plan cancer surgery. PURPOSE: This laboratory study is looking at a new blood test to detect abnormal clotting in patients with metastatic cancer undergoing surgery.
Key facts
- Study ID
- NCT00096590
- Run by
- National Cancer Institute (NCI)
- People needed
- 60
- Starts
- 2004-11-01
- Last updated by the study team
- 2009-05-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.